The Tale of Two Studies: Long-term treatment results from RA & PsA

Introduction

Take This Event

We are pleased to invite you to the webinar titled ‘The Tale of Two Studies: Long-term treatment results from RA & PsA.' This interactive webinar aims to share with the rheumatology community the latest long-term efficacy and safety data for both RA and PsA.

Objectives

Provide information to rheumatologists on approved JAK inhibitors in the management of Rheumatoid Arthritis and IL 17 in the management of Psoriatic Arthritis and to share efficacy, safety related data

See Registration Policies, Cancellations & Refunds